Foster 100/6

Beclometasone + Formetrol

Therapeutic Indication:
  • Asthma: Foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate, patients not adequately controlled with inhaled corticosteroids and as-needed inhaled rapid-acting beta2-agonist, or for patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.
  • COPD: Symptomatic treatment of patients with severe COPD (FEV1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.


  • Composition: Beclometasone Dipropionate Anhydrous 100 mcg/Actuation, Formoterol Fumarate Dihydrate 6 mcg/Actuation.
  • Pharmaceutical Form: Pressurized Solution for inhalation.
  • Method of Administration: Inhalation.
  • How Supplied: Single Inhaler, 120 Actuations.
  • Manufacturer: Chiesi Farmaceutici, Italy.

Contact Us

Contact us today to find out more about our services and discuss your enquiries.